ResearcherQingdao UniversityActive in the last 2 years
Bin Zhou
Matched on ORCID iD 0000-0002-2857-6648; OpenAlex author ID A5054802652. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2012: 2 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 8
- Crosstalk between pancreatic cancer and adipose tissue: Molecular mechanisms and therapeutic implications. Co-author DOI 10.1016/j.bbrc.2024.151012↗
- Steroid treatment response combined with serological mark in differentiating type-1 autoimmune pancreatitis from pancreatic cancer. Co-author DOI 10.1097/md.0000000000031660↗
- Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. Co-author DOI 10.1016/j.omtn.2021.06.001↗
- Obesity and pancreatic cancer: An update of epidemiological evidence and molecular mechanisms. Co-author DOI 10.1016/j.pan.2019.08.008↗
- Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to-Mesenchymal Transition in Human Pancreatic Cancer Cell. Co-author DOI 10.3349/ymj.2018.59.1.20↗
- Therapy of Smac mimetic SM-164 in combination with gemcitabine for pancreatic cancer. Co-author DOI 10.1016/j.canlet.2012.10.039↗
- NOP14 promotes proliferation and metastasis of pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2012.03.010↗
- Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.4161/cbt.20839↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhiyao Fan · 2 shared papers, 2021–2024 · strength 0.43
- Paper Crosstalk between pancreatic cancer and adipose tissue: Molecular mechanisms and therapeutic implications. DOI 10.1016/j.bbrc.2024.151012↗
- Paper Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. DOI 10.1016/j.omtn.2021.06.001↗
- Hanxiang Zhan · 2 shared papers, 2019–2024 · strength 0.41
- Boyu Diao · 1 shared paper, 2024 · strength 0.31
- Sanyuan Hu · 2 shared papers, 2019–2021 · strength 0.21
- Yunshan Wang · 2 shared papers, 2019–2021 · strength 0.21
- Bingqian Liu · 1 shared paper, 2022 · strength 0.17
- Bin Liu · 1 shared paper, 2022 · strength 0.17
- Hua Li · 1 shared paper, 2022 · strength 0.17
- Jian Yang · 1 shared paper, 2021 · strength 0.12
- Bingyuan Zhang · 1 shared paper, 2021 · strength 0.12
- Yongzheng Li · 1 shared paper, 2021 · strength 0.12
- Zhaowei Sun · 1 shared paper, 2021 · strength 0.12
- Hanxiang Zhan · 1 shared paper, 2021 · strength 0.12
- Jianwei Xu · 1 shared paper, 2019 · strength 0.10
- Han Liu · 1 shared paper, 2019 · strength 0.10
- Ge Chen · 2 shared papers, 2012–2013 · strength 0.08
- Yu-Pei Zhao · 2 shared papers, 2012–2013 · strength 0.08
- Taiping Zhang · 2 shared papers, 2012–2013 · strength 0.08
- Xiaoyu Li · 1 shared paper, 2018 · strength 0.07
- Cuiping Zhang · 1 shared paper, 2018 · strength 0.07
- Jun Wu · 1 shared paper, 2018 · strength 0.07
- Qinghui Niu · 1 shared paper, 2018 · strength 0.07
- Jie Zhang · 1 shared paper, 2013 · strength 0.04
- Lei You · 1 shared paper, 2013 · strength 0.04
- Yu-Pei Zhao · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.